BioXcel Therapeutics, Inc. (NASDAQ:BTAI) Short Interest Up 285.4% in May
BioXcel Therapeutics, Inc. (NASDAQ:BTAI – Get Free Report) was the recipient of a large growth in short interest in May. As of May 31st, there was short interest totalling 515,700 shares, a growth of 285.4% from the May 15th total of 133,800 shares. Currently, 9.3% of the company’s stock are sold short. Based on an […]
BioXcel Therapeutics, Inc. (NASDAQ:BTAI – Get Free Report) was the recipient of a large growth in short interest in May. As of May 31st, there was short interest totalling 515,700 shares, a growth of 285.4% from the May 15th total of 133,800 shares. Currently, 9.3% of the company’s stock are sold short. Based on an […]
